Differential effects on cell cycle regulators by AML1-ETO and a C-terminal truncated AML1-ETO (From tumor suppressor to oncogene).

被引：0
|
作者：
Peterson, LF [1 ]
Yan, M [1 ]
Boyapati, A [1 ]
Zhang, DE [1 ]
机构：
[1] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.2052.2052
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2052
引用
收藏
页码：565A / 565A
页数：1
相关论文
共 50 条
  • [21] Targeted disruption of the interaction between AML1-ETO and the nuclear receptor co-repressor induces apoptosis of AML1-ETO leukemia cells.
    Saunthararajah, Y
    Wang, JX
    Futaki, M
    Igarashi, T
    Redner, RL
    Liu, JM
    BLOOD, 2000, 96 (11) : 458A - 459A
  • [22] AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML
    Jonathan D Licht
    Oncogene, 2001, 20 : 5660 - 5679
  • [23] AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression
    Yeh, Jing-Ruey J.
    Munson, Kathleen M.
    Chao, Yvonne L.
    Peterson, Quinn P.
    MacRae, Calum A.
    Peterson, Randall T.
    DEVELOPMENT, 2008, 135 (02): : 401 - 410
  • [24] ABL1 kinase as a tumor suppressor in AML1-ETO and NUP98-PMX1 leukemias
    Golovine, Konstantin
    Abalakov, Gleb
    Lian, Zhaorui
    Chatla, Srinivas
    Karami, Adam
    Chitrala, Kumaraswamy Naidu
    Madzo, Jozef
    Nieborowska-Skorska, Margaret
    Huang, Jian
    Skorski, Tomasz
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [25] ABL1 kinase as a tumor suppressor in AML1-ETO and NUP98-PMX1 leukemias
    Konstantin Golovine
    Gleb Abalakov
    Zhaorui Lian
    Srinivas Chatla
    Adam Karami
    Kumaraswamy Naidu Chitrala
    Jozef Madzo
    Margaret Nieborowska-Skorska
    Jian Huang
    Tomasz Skorski
    Blood Cancer Journal, 13
  • [26] Deletion of an AML1-ETO C-terminal NcoR/SMRT-interacting region strongly induces leukemia development
    Ming, Y
    Burel, SA
    Peterson, LF
    Kanbe, E
    Iwasaki, H
    Boyapati, A
    Hines, R
    Akashi, K
    Zhang, DE
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (49) : 17186 - 17191
  • [27] AML1-ETO targets and suppresses cathepsin G, a serine protease, which is able to degrade AML1-ETO in t(8;21) acute myeloid leukemia
    W Jin
    K Wu
    Y-Z Li
    W-T Yang
    B Zou
    F Zhang
    J Zhang
    K-K Wang
    Oncogene, 2013, 32 : 1978 - 1987
  • [28] AML1-ETO targets and suppresses cathepsin G, a serine protease, which is able to degrade AML1-ETO in t(8;21) acute myeloid leukemia
    Jin, W.
    Wu, K.
    Li, Y-Z
    Yang, W-T
    Zou, B.
    Zhang, F.
    Zhang, J.
    Wang, K-K
    ONCOGENE, 2013, 32 (15) : 1978 - 1987
  • [29] AML1 and AML1 fusion protein AML1-ETO in myeloid gene regulation and leukemogenesis
    Zhang, DE
    Burel, S
    Zhou, LM
    Hetherington, CJ
    Yuan, YZ
    BLOOD CELLS MOLECULES AND DISEASES, 2001, 27 (02) : 368 - 376
  • [30] TAFII250 Is Critical in AML1-ETO Mediated Leukemogenesis
    Xu, Ye
    Man, Na
    Martinez, Concepcion
    Martinez, Camilo
    Beckedorf, Felipe
    Cheng, Guoyan
    Greenblatt, Sarah Merin
    Wang, Lan
    Shiekhattar, Ramin
    Nimer, Stephen D.
    BLOOD, 2016, 128 (22)
12345